pixantrone has been researched along with Cancer of Kidney in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allievi, C; Houghton, PJ; Kang, MH; Kurmasheva, RT; Reynolds, CP; Smith, MA | 1 |
1 other study(ies) available for pixantrone and Cancer of Kidney
Article | Year |
---|---|
Initial testing (stage 1) of the topoisomerase II inhibitor pixantrone, by the pediatric preclinical testing program.
Topics: Animals; Bone Neoplasms; Cell Proliferation; DNA Topoisomerases, Type II; Drug Evaluation, Preclinical; Female; Humans; Isoquinolines; Kidney Neoplasms; Mice; Mice, SCID; Rhabdomyosarcoma; Sarcoma, Ewing; Tissue Distribution; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Wilms Tumor; Xenograft Model Antitumor Assays | 2014 |